Shamez Ladhani to Vaccines, Conjugate
This is a "connection" page, showing publications Shamez Ladhani has written about Vaccines, Conjugate.
Connection Strength
2.564
-
Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018. Vaccine. 2019 07 26; 37(32):4491-4498.
Score: 0.653
-
Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature. Br J Haematol. 2019 05; 185(4):743-751.
Score: 0.639
-
Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014. Clin Infect Dis. 2017 10 01; 65(7):1191-1198.
Score: 0.578
-
The Pneumococcus and Its Critical Role in Public Health. Methods Mol Biol. 2019; 1968:205-213.
Score: 0.158
-
The Epidemiology and Biostatistics of Pneumococcus. Methods Mol Biol. 2019; 1968:215-224.
Score: 0.158
-
Rapid Spread of Pneumococcal Nonvaccine Serotype 7C Previously Associated with Vaccine Serotype 19F, England and Wales. Emerg Infect Dis. 2018 10; 24(10):1919-1922.
Score: 0.155
-
Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and Wales. J Infect. 2018 04; 76(4):335-341.
Score: 0.147
-
Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18. Thorax. 2020 01; 75(1):38-49.
Score: 0.042
-
Risk of invasive meningococcal disease in university students in England and optimal strategies for protection using MenACWY vaccine. Vaccine. 2017 10 13; 35(43):5814-5818.
Score: 0.036